EdgarLookup
8-K

FROM 8-K

Company
BRAINSTORM CELL THERAPEUTICS INC.
Filed
August 7, 2012
Period of Report
August 1, 2012
Accession Number
0001144204-12-043175

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →